Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $34.3300 (-0.41%) ($33.8500 - $35.8200) on Fri. Dec. 28, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.53% (three month average) | RSI | 37 | Latest Price | $34.3300(-0.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -11.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) ARKG(51%) IBB(50%) IWO(50%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -2.265% in a week (0% probabilities). VXX(-14%) TLT(-14%) VIXM(-12%) UUP(-12%) UNG(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.265% (StdDev 4.53%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
1 - 5 Day Possible Target | $15.81(-53.95%) | Resistance Level | $38.36 | 5 Day Moving Average | $32.97(4.12%) | 10 Day Moving Average | $35.55(-3.43%) | 20 Day Moving Average | $38.36(-10.51%) | To recent high | -20.1% | To recent low | 11.1% | Market Cap | $2.551b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |